Herantis Pharma Oyj: Manager’s Transactions – Mats Heiman

Herantis Pharma Plc
Company release 13 Mar 2019 at 9:00 am

Herantis Pharma Oyj: Manager’s Transactions – Mats Heiman

Herantis Pharma Plc
Company release 13 March 2019 at 9:00 am

Herantis Pharma Oyj – Managers’ Transactions

____________________________________________

Person subject to the notification requirement

Name: Mats Heiman

Position: Closely associated person

(1):Person Discharging Managerial Responsibilities In Issuer

Name: Ingrid Atteryd Heiman

Position: Member of the Board

Issuer: Herantis Pharma Oyj

LEI: 743700W4CQVYAT3WKK38

Notification type: INITIAL NOTIFICATION

Reference number: 743700W4CQVYAT3WKK38_20190312215059_9

____________________________________________

Transaction date: 2019-03-12

Venue not applicable

Instrument type: SHARE

ISIN: FI4000087861

Nature of the transaction: SUBSCRIPTION

Transaction details

(1): Volume: 10,000 Unit price: 5.2 EUR

Aggregated transactions

(1): Volume: 10,000 Volume weighted average price: 5.2 EUR

____________________________________________

Further information:

Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Securities Ltd, telephone: +358 9 25 380 225

Distribution:

Nasdaq Helsinki
Main media
www.herantis.com